Feasibility of using laboratory glucose to diagnose undiagnosed diabetes in hospital by Farmer, A, Shine, B, Armitage, L, Murphy, N, James, T, Guha, N, Rea, R

The potential for utilising in-hospital glucose measurements to detect individuals at high risk of previously undiagnosed diabetes: retrospective cohort study by Farmer, AJ, Shine, B, Armitage, LC, Murphy, N, James, T, Guha, N, Rea, R

Use of FGF-21 as a biomarker of mitochondrial disease in clinical practice by Morovat, A, Weerasinghe, G, Nesbitt, V, Hofer, M, Agnew, T, Quaghebeur, G, Sergeant, K, Fratter, C, Guha, N, Mirzazadeh, M, Poulton, J

Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimize treatment outcome in genotype 1 noncirrhotic treatment-naïve patients with chron... by Fawsitt, C, Vickerman, P, Cooke, G, Barnes, E, Ball, J, Brainard, D, Burgess, G, Dillon, J, Foster, G, Gore, C, Guha, N, Halford, R, Whitby, K, Holmes, C, Howe, A, Hudson, E, Hutchinson, S, Irving, W, Khakoo, S, Klenerman, P, Martin, N, Massetto, B, Mbisa, T, McHutchison, J, McKeating, J, McLauchlan, J, Miners, A, Murray, A, Shaw, P, Simmonds, P, Spencer, C, Thomson, E, Zitzmann, N, Welton, N

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus by Ansari, M, Aranday-Cortes, E, Ip, C, Da Silva Filipe, A, Lau, S, Bamford, C, Bonsall, D, Trebes, A, Piazza, P, Sreenu, V, Cowton, V, Stop-Hcv Consortium, Ball, J, Barnes, E, Burgess, G, Cooke, G, Dillon, J, Foster, G, Gore, C, Guha, N, Halford, R, Holmes, C, Hudson, E, Hutchinson, S, Irving, W, Khakoo, S, Klenerman, P, Martin, N, Mbisa, T, McKeating, J, McLauchlan, J, Miners, A, Murray, A, Shaw, P, Simmonds, P, Smith, S, Spencer, C, Thomson, E, Troke, P, Vickerman, P, Zitzmann, N, Hudson, E, Bowden, R, Patel, A, Foster, G, Irving, W, Agarwal, K, Thomson, E, Simmonds, P, Klenerman, P, Holmes, C, Barnes, E, Spencer, C, McLauchlan, J, Pedergnana, V